Mitapivat
- Generic Name
- Mitapivat
- Brand Names
- Pyrukynd 5 Mg 4-week, Pyrukynd
- Drug Type
- Small Molecule
- Chemical Formula
- C24H26N4O3S
- CAS Number
- 1260075-17-9
- Unique Ingredient Identifier
- 2WTV10SIKH
- Background
Mitapivat is a novel, first-in-class pyruvate kinase activator. It works to increase the activity of erythrocyte pyruvate kinase, a key enzyme involved in the survival of red blood cells. Defects in the pyruvate kinase enzyme in various red blood cells disorders lead to the lack of energy production for red blood cells, leading to lifelong premature destruct...
- Indication
Mitapivat is indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency.
- Associated Conditions
- Pyruvate Kinase Deficiency Anemia
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath